Skip to content
A new partnership will use biotechnology to bring baby formula closer to mothers’ milk, Good Day BIO reports. Ginkgo Bioworks announced yesterday it’s partnering […]
Ginkgo Bioworks will use biotech to boost baby formula’s gut-health properties Read More »
With avian flu driving up the price of farmed fowl and eggs, biotech solutions to help us boost protein grow more important. The problem
Biotech can beef up our protein sources Read More »
Pfizer Inc. announced on Tuesday it is expanding its initiative focused on reducing health inequities in many lower-income countries by offering “the full portfolio
Pfizer expands access to full drug portfolio worldwide Read More »
The cost of innovative gene therapies to treat and eradicate sickle cell disease (SCD) is far lower than the lifetime medical expenses of having
The true cost of sickle cell disease treatment Read More »
Kindergarten vaccination rates have dropped dramatically since the start of the COVID-19 pandemic, and experts say it’s due to vaccine hesitancy. The 2019–2020 school
Kindergarten vaccination rates fall due to vaccine hesitancy Read More »
The biotechnology industry is one of the riskiest and the most challenging—but it is also one of the few that makes the difference between
2022 was a challenging year for biotechnology. What’s in store for 2023? Read More »
The annual meeting of the World Economic Forum (WEF) kicked off in Davos yesterday, and continues all week, putting a focus on food insecurity
Davos: Biotech can help address food insecurity and climate change Read More »
Alarming new climate records highlight the need for biotech solutions, ASAP. According to a report published by the European Union’s Copernicus Climate Change Service,
What’s up with the weather – and why it matters to biotech Read More »
In their efforts to harness a new way “to turn cancer cells into potent anticancer agents,” researchers developed a new stem cell therapy to
This vaccine can simultaneously kill and prevent brain cancer Read More »
Despite the fact the United States is still dealing with the COVID-19 pandemic, the Center for Drug Evaluation and Research (CDER) of the U.S.
FDA approved 37 ‘novel’ drugs in 2022, says new analysis Read More »
